1. Home
  2. LNC vs DVA Comparison

LNC vs DVA Comparison

Compare LNC & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln National Corporation

LNC

Lincoln National Corporation

HOLD

Current Price

$39.90

Market Cap

8.5B

Sector

Finance

ML Signal

HOLD

Logo DaVita Inc.

DVA

DaVita Inc.

HOLD

Current Price

$150.73

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LNC
DVA
Founded
1905
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Misc Health and Biotechnology Services
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.2B
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
LNC
DVA
Price
$39.90
$150.73
Analyst Decision
Hold
Hold
Analyst Count
12
4
Target Price
$45.92
$156.75
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
01-01-0001
05-04-2026
Dividend Yield
4.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
9.84
Revenue
N/A
$13,643,069,000.00
Revenue This Year
$11.29
$3.80
Revenue Next Year
$3.74
$3.04
P/E Ratio
$7.17
$15.32
Revenue Growth
N/A
6.46
52 Week Low
$27.58
$101.00
52 Week High
$46.82
$157.12

Technical Indicators

Market Signals
Indicator
LNC
DVA
Relative Strength Index (RSI) 42.91 70.37
Support Level $39.65 $146.08
Resistance Level $42.25 $152.67
Average True Range (ATR) 1.39 6.41
MACD 0.11 1.36
Stochastic Oscillator 27.21 91.83

Price Performance

Historical Comparison
LNC
DVA

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability and dental.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: